A meta-analysis of the association between gestational diabetes mellitus and chronic hepatitis B infection during pregnancy

BMC Research Notes

Yingjie Zheng¹  Yihan Lu⁵  Naiqing Zhao²  Wenhui Han⁴  Anqun Hu³  Yan Wang⁴  Shan Wei⁵  Haiyan Liu³  Dechuan Kong⁵ 

[1] Department of Sanitary Microbiology, School of Public Health, Fudan University, Shanghai 200032, China;Department of Biostatistics, School of Public Health, Fudan University, Shanghai 200032, China;Department of Clinical Laboratory, Anqing City Hospital, Anqing 246003, Anhui Province, China;Department of Gynaecology and Obstetrics, Anqing City Hospital, Anqing 246003, Anhui Province, China;The Key Laboratory on Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China

关键词: Meta-analysis;    Pregnant women;    Gestational diabetes mellitus;    Chronic hepatitis B infection;   

Others  :  1134307
DOI  :  10.1186/1756-0500-7-139

 received in 2013-10-25, accepted in 2014-03-04,  发布年份 2014

【 摘 要 】

Background

Chronic hepatitis B (CHB) infection during pregnancy is associated with insulin resistance. A meta-analytic technique was used to quantify the evidence of an association between CHB infection and the risk of gestational diabetes (GDM) among pregnant women.

Methods

We searched PubMed for studies up to September 5th 2013. Additional studies were obtained from other sources. We selected studies using a cohort-study design and reported a quantitative association between CHB infection during pregnancy and risk of GDM. A total of 280 articles were identified, of which fourteen publications involving 439,514 subjects met the inclusion criteria. A sequential algorithm was used to reduce between-study heterogeneity, and further meta-analysis was conducted using a random-effects model.

Results

Ten out of the fourteen studies were highly homogeneous, indicating an association of 1.11 [the adjusted odds ratio, 95% confidence interval 0.96 - 1.28] between CHB infection during pregnancy and the risk of developing GDM. The heterogeneity of the additional four studies may be due to selection bias or possible aetiological differences for special subsets of pregnant women.

Conclusions

These results indicate that CHB infection during pregnancy is not associated with an increased risk of developing GDM among pregnant women except those from Iran.

【 授权许可】

   
2014 Kong et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11(2):97-107.
• [2]Tan HH, Lui HF, Chow WC: Chronic hepatitis B virus (HBV) infection in pregnancy. Hepato int 2008, 2(3):370-375.
• [3]Wong S, Chan LY, Yu V, Ho L: Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999, 16(9):485-488.
• [4]Lao TT, Tse KY, Chan LY, Tam KF, Ho LF: HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Diabetes Care 2003, 26(11):3011-3016.
• [5]To WW, Cheung W, Mok KM: Hepatitis B surface antigen carrier status and its correlation to gestational hypertension. Aust N Z J Obstet Gynaecol 2003, 43(2):119-122.
• [6]Tse KY, Ho LF, Lao TT: The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol 2005, 43(5):771-775.
• [7]Lao TT, Chan BC, Leung WC, Ho LF, Tse KY: Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007, 47(1):46-50.
• [8]Lert-amornpong S, Caengow S, Chutaputti A: The association of pregnancy outcomes and HBsAg positive. Thai J Gastroenterol 2007, 8(3):115-118.
• [9]Thungsuk R: Maternal hepatitis B infection and pregnancy outcomes. J Prapokklao Hosp Clin Med Educat 2008, 25(3):246-254.
• [10]Saleh-Gargari S, Hantoushzadeh S, Zendehdel N, Jamal A, Aghdam H: The association of maternal HBsAg carrier status and perinatal outcome. Hepat Mon 2009, 9(3):180-184.
• [11]Aghamohammadi A, Nooritajer M: Maternal hbsag carrier and pregnancy outcome. Aust J Basic & Appl Sci 2011, 5(3):607-610.
• [12]Lobstein S, Faber R, Tillmann HL: Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion 2011, 83(1–2):76-82.
• [13]Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK: Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011, 18(7):e394-398.
• [14]Lao TT, Sahota DS, Suen SS, Law LW, Leung TY: Maternal HBsAg status and infant size–a Faustian bargain? J Viral Hepat 2012, 19(7):519-524.
• [15]Lu YP, Chen YP, Xiao XM, Liang XJ, Li J, Huang SM, Chen X, Hocher Berthold HB: [Impact of maternal hepatitis B surface antigen carrier status on preterm delivery in southern China]. Nan Fang Yi Ke Da Xue Xue Bao 2012, 32(9):1369-1372.
• [16]Lao TT, Sahota DS, Cheng YK, Law LW, Leung TY: Maternal hepatitis B surface antigen status and incidence of pre-eclampsia. J Viral Hepat 2013, 20(5):343-349.
• [17]Mak SL, Leung KY: Hepatitis B carriers in Hong Kong: prevalence and pregnancy outomes. HKJGOM 2013, 13(1):67-73.
• [18]Yue DK, Molyneaux LM, Ross GP, Constantino MI, Child AG, Turtle JR: Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med 1996, 13(8):748-752.
• [19]Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352(24):2477-2486.
• [20]Picardi A, D’Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A: Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006, 22(4):274-283.
• [21]White DL, Ratziu V, El-Serag HB: Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008, 49(5):831-844.
• [22]Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, Cheong J, Jeong DW, Lee YH, Cho YH, Bae MJ, Choi EJ: Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol 2012, 18(42):6120-6126.
• [23]Li-Ng M, Tropp S, Danoff A, Bini EJ: Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis 2007, 39(6):549-556.
• [24]Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH: Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation. J Gastroenterol Hepatol 2010, 25(8):1420-1425.
• [25]Zheng Y, Lu Y, Ye Q, Xia Y, Zhou Y, Yao Q, Wei S: Should chronic hepatitis B mothers breastfeed? A meta analysis. BMC public health 2011, 11:502. BioMed Central Full Text
• [26]Wells G, Shea BO, Connell D: The Newcastle-Ottawa Scale (Nos) For Assessing The Quality Of Nonrandomized Studies In Meta-Analysis. 2010. http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt webcite
• [27]Greenland S: Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987, 9:1-30.
• [28]Patsopoulos NA, Evangelou E, Ioannidis JP: Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008, 37(5):1148-1157.
• [29]Altman DG, Bland JM: Interaction revisited: the difference between two estimates. BMJ 2003, 326(7382):219.
• [30]Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
• [31]Duval S, Tweedie R: A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc 2000, 95(449):89-98.
• [32]Higgins JP, Thompson SG, Spiegelhalter DJ: A re-evaluation of random-effects meta-analysis. J R Stat Soc 2009, 172(1):137-159.
• [33]Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 1997, 20(9):1368-1369.
• [34]Hernan MA, Hernandez-Diaz S, Robins JM: A structural approach to selection bias. Epidemiology 2004, 15(5):615-625.
• [35]Higgins JP: Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008, 37(5):1158-1160.
• [36]Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE: Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatol (Baltimore, Md) 2012, 55(1):77-85.
• [37]Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatol (Baltimore, Md) 2001, 33(6):1358-1364.
• [38]Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J: Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003, 125(6):1695-1704.
• [39]Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK: Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006, 13(5):303-310.